肿瘤标志物在肺癌检验中的临床应用探索

Clinical application of tumor markers in lung cancer verification

为研究肿瘤标志物在肺癌检验中的作用，哈尔滨市第一专科医院选择2013年1月至2015年5月期间收治的52例肺癌患者作为观察组，另选择同期本院收治的非恶性肿瘤肺部疾病患者30例作为对照组，比较两组患者肿瘤标志物（CYFRA21—1、FER、NSE、CEA）阳性检出率，并分类比较不同病理分型患者各肿瘤标志物阳性检出率情况。实验证明，肺癌检验中CYFRA21—1阳性检出水平最高，检验准确性最为理想，可与其他标志物联合检测，以提高确诊准确率。

With 52 lung cancer patients admitted during January 2013 and May 2015 in the first specialized hospital of Harbin were chosen as observed group and another 30 patients with nonmalignant tumorpulmonary disease in the same period as control group, investigation of the role of tumor marker in lung cancer verification was applied. Positive detection rate of tumor markers （CYFRA21-1 ,FER,NSE ,CEA） in the two groups were compared and the detection rate of different markers was analyzed according to the pathology types. The results suggesting that, CYFRA 21-1 positive detection level is the highest in lung cancer verification and with ideal accuracy, it can be used combining with other markers to promote the accurate rate.